Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy

Area of Science:

• Immunology
• Genetics
• Cardiovascular Medicine

Background:

• Tumor necrosis factor alpha (TNF-alpha) is a proinflammatory cytokine produced by macrophages.
• TNF-alpha influences vascular permeability, endothelial function, and thrombotic state.
• A common TNF-alpha gene polymorphism involves a gamma to alpha substitution (TNF2 allele) in the promoter region, associated with elevated TNF-alpha.

Purpose of the Study:

• To investigate the association between the TNF-alpha gene polymorphism (TNF1 vs. TNF2 alleles) and heart disease.
• To determine if the TNF2 allele, a stronger transcriptional activator, correlates with increased risk of coronary artery disease or cardiomyopathy/heart failure.

Main Methods:

• Review of existing studies examining the TNF-alpha gene polymorphism (specifically the TNF2 allele) in relation to cardiovascular conditions.
• Analysis of data linking TNF-alpha levels and the presence of coronary artery disease, cardiomyopathy, and heart failure.

Main Results:

• The TNF2 allele is a more potent transcriptional activator, leading to higher circulating levels of TNF-alpha.
• Despite the association with elevated TNF-alpha, most studies have not found a conclusive link between this polymorphism and heart disease.
• No definitive association was established for coronary artery disease or cardiomyopathy/heart failure.

Conclusions:

• While the TNF2 allele increases TNF-alpha production, current evidence does not support a causal relationship with common forms of heart disease.
• Further research may be needed to clarify the role of TNF-alpha in cardiovascular pathophysiology and potential genetic influences.